Compare Northern Trust Corporation Common Stock (NTRS) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Northern Trust Corporation Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Northern Trust Corporation Common Stock trades at $162.48 (market cap $30.63B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Northern Trust Corporation Common Stock is far larger — about 2.8× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Northern Trust Corporation Common Stock pays the higher dividend (1.96%). Which is the better fit depends on your goals — on Pluang, investors hold Northern Trust Corporation Common Stock for 0 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| NTRS | RDY | |
|---|---|---|
Market Cap | $30.63B | $10.78B |
Volume | 964,550 | 2,724,343 |
Sector | Financials | Health |
52-Week High | $191.47 | $15.38 |
52-Week Low | $122.72 | $11.38 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | -$5.35B | $10.68B |
Dividend Yield | 1.96% | 0.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Northern Trust Corporation Common Stock
Northern Trust Corporation is a financial holding company that provides asset servicing, asset management, wealth management, and banking services through its Asset Servicing and Wealth Management segments. It serves corporations, institutions, and affluent individuals across US and international markets.
Read more on NTRS →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
